MCMichaela Chocholouskova

Michaela Chocholouskova

*This is an algorithmically generated author record based on publicly available information.

Michaela Chocholouskova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Angelica Delgado Vega

    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Ann Nordgren

    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Cheen Fei Chin

    Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore

    1 shared publication
  • David L. Silver

    Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore

    1 shared publication
  • Federico Torta

    Precision Medicine Translational Research Programme and Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; SLING, Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore

    1 shared publication
  • Helena Malmgren

    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Open Access

    SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis

    by Menglan He, Mei Ding, Michaela Chocholouskova, Cheen Fei Chin, Martin Engvall, Helena Malmgren, Matias Wagner, Marlen C. Lauffer, Jacob Heisinger, May Christine V. Malicdan, et al.

    SPNS1 is a lysosomal transporter that mediates the salvage of lysoglycerophospholipids, the degradative products of lysosomal phospholipid catabolism. However, an understanding of the role of lysolipid transport and salvage in regulating cellular lipid homeostasis and in disease is lacking. Here, we identified members of 2 families with biallelic SPNS1 loss-of-function variants, who presented primarily with progressive liver and striated muscle injury. Patients’ fibroblasts accumulated lysophospholipids including lysoplasmalogens and cholesterol in lysosomes with reduced cellular plasmalogens. Notably, SPNS1 deficiency resulted in reduced biogenesis of cytosolic lipid droplets containing triglycerides and cholesteryl esters. Mechanistically, we found that lysophospholipids transported by SPNS1 into the cytosol quantitatively contributed to triglyceride synthesis, whereas lysosomal buildup of lyso-ether-phospholipid inhibited lysosomal cholesterol egress, effects that were enhanced with inhibition of mTOR. These findings support a gene-disease association and reveal connectivity between lysosomal transport of lysophospholipids and storage of reserve cellular energy as triglycerides and the regulation of cholesterol homeostasis, processes that become important under nutrient limitation.